Medical Imaging Bundle

Table of Contents

Mammography World Markets

1. Overview

• 1.1 Statement of Report
• 1.2 Scope of this Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Overview of the Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
  • 2.1.1 Global Medical Imaging Market
  • 2.1.2 U.S. Medical Imaging Market
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiologic Services
  • 2.2.5 Overview of Medical Imaging Market Segments
  • 2.2.6 Market Drivers
    • 2.2.6.1 Product Enhancements Drive Adoption of Imaging Procedures among End Users
    • 2.2.6.2 Potential of Novel Contrast Agents Development to Drive Imaging Procedure Volumes
    • 2.2.6.3 Rapid Pace of Innovation Narrows Product Lifecycles and Restricts Spending
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for Medical Imaging
    • 2.2.8.1 Discovery
    • 2.2.8.2 Clinical Applications
    • 2.2.8.3 Clinical Trials
    • 2.2.8.4 Outpatient Facilities Best Growth Market
    • 2.2.8.5 Diagnostic Imaging Modalities Witness Several Technology Advancements
    • 2.2.8.6 Safety and Ergonomics Concerns Drive Technology Growth
    • 2.2.8.7 Volumetric Imaging and Post-image Processing Techniques Develop Rapidly
    • 2.2.8.8 Increasing Implementation of PACS Pushes Digital Radiography into High Gear
    • 2.2.8.9 Future Price Reduction Set to Stimulate Wider Acceptance of DR Systems
    • 2.2.8.10 High-performance Imaging Combined with Lower Radiation Doses Spurs Growth of DR
• 2.3 Contrast Media
  • 2.3.1 Market Share
  • 2.3.2 Market Drivers
• 2.4 Picture Archiving Communications Systems
  • 2.4.1 Picture Archiving Communications Systems and Radiology Information Systems
  • 2.4.2 Increasing Digitization of Cardiology-Image Storage and Management Creates Market Growth Opportunities
  • 2.4.3 Enterprise-Wide Integration Is an Important Area for Future Market Development
  • 2.4.4 Competition among Large Companies Intensifies
  • 2.4.5 Benefits of This Service
  • 2.4.6 Market Sectors
  • 2.4.7 Digital Imaging Technology Platforms
• 2.5 Medical Imaging Companies
  • 2.5.1 A Few Firms Dominate the Industry
• 2.6 Medical Imaging Industry Forecasts
• 2.7 Market Niches and Digitalization
• 2.8 Digital Imaging Techniques
  • 2.8.1 Clinical Uses
  • 2.8.2 Product Enhancements Drive Adoption of Imaging Devices among End-Users
  • 2.8.3 Rapid Pace of Innovation Narrows Product Lifecycles and Restricts Spending
  • 2.8.4 Current and New Digital Imaging Procedures
  • 2.8.5 The Digital Impact on Clinical Imaging Markets
  • 2.8.6 Trends in Digital Imaging
  • 2.8.7 Enhancing Computed Radiography
  • 2.8.8 Digital Radiography vs. Computed Radiography
  • 2.8.9 DR Products
  • 2.8.10 Vasodilator Perfusion Imaging

3. World Mammography Market

• 3.1 Mammography Overview
• 3.2 Market Overview
  • 3.2.1 Introduction to Market Overview
  • 3.2.2 World Mammography Markets Revenue
  • 3.2.3 Mammography Markets by Region
  • 3.2.4 Total Market Share
  • 3.2.5 Competitive Structure
• 3.3 Market Opportunities
  • 3.3.1 Resource Management for Mammography Markets
  • 3.3.2 Movement to Higher Reimbursement Rates
  • 3.3.3 Market Benchmarks for Increased Mammography Utilization
• 3.4 Market Analysis
  • 3.4.1 Strategic Partnerships
  • 3.4.2 Long Term Trends
• 3.5 Strategic Outlook
  • 3.5.1 Competitive Elements of Mammography Markets
  • 3.5.2 Higher Reimbursement Rates
  • 3.5.3 Volume Requirements
  • 3.5.4 Product Innovation
  • 3.5.5 Product Leadership
  • 3.5.6 Product Line Strategy
  • 3.5.7 Pricing Strategy and Reimbursement
  • 3.5.8 Strategic Partnerships
• 3.6 Film-based Mammography Market
  • 3.6.1 Market Overview
    • 3.6.1.1 Unit and Revenue Forecasts
    • 3.6.1.2 Product Analysis
  • 3.6.2 Market Drivers
  • 3.6.3 Market Restraints
  • 3.6.4 Film-based Mammography Market and Technology Trends
  • 3.6.5 U.S. Market for Film-based Screening Systems
    • 3.6.5.1 Unit Shipment and Revenue Forecasts
    • 3.6.5.2 Competitive Analysis
    • 3.6.5.3 U.S. Installed Base Analysis
  • 3.6.6 European Market for Film-based Mammography Systems
    • 3.6.6.1 Unit Shipment and Revenue Forecasts
    • 3.6.6.2 Competitive Analysis
    • 3.6.6.3 Installed Base Analysis
  • 3.6.7 Japanese (Pacific Rim) Market for Film-based Mammography Systems
    • 3.6.7.1 Unit Shipment and Revenue Forecasts
    • 3.6.7.2 Competitive Analysis
    • 3.6.7.3 Installed Base Analysis
  • 3.6.8 Rest of the World Market for Analog Screening Systems
    • 3.6.8.1 Unit Shipment and Revenue Forecasts
    • 3.6.8.2 Installed Base Analysis
• 3.7 Digital X-ray Mammography Market
  • 3.7.1 Digital Mammography Overview
  • 3.7.2 Market Overview
  • 3.7.3 Product Background
  • 3.7.4 Product Description
  • 3.7.5 Market Drivers
  • 3.7.6 Market Restraints
  • 3.7.7 Unit Shipment and Revenue Forecasts
  • 3.7.8 Percentage Breakdown of Revenues by Region
  • 3.7.9 Market Share
  • 3.7.10 U.S. Market for Digital Mammography Systems
    • 3.7.10.1 Unit Sales
    • 3.7.10.2 Competitive Analysis
    • 3.7.10.3 U.S. Installed Base Analysis
  • 3.7.11 European Market for Digital Mammography Systems
    • 3.7.11.1 Unit Shipment and Revenue Forecasts
    • 3.7.11.2 Competitive Analysis
    • 3.7.11.3 Installed Base Analysis
  • 3.7.12 Japanese (Pacific Rim) Market for Digital Mammography Systems
    • 3.7.12.1 Unit Shipment and Revenue Forecasts
    • 3.7.12.2 Competitive Analysis
    • 3.7.12.3 Installed Base Analysis

4. Mammography: Growth Regulators

• 4.1 Moderators of Growth
• 4.2 Personnel Acceptance
• 4.3 Key People for Mammography
• 4.4 Key Elements for Mammography
• 4.5 Satellite Facilities
• 4.6 Reimbursement for Mammography

5. Business Trends in the Industry

• 5.1 Sector Consolidation
• 5.2 Mammographic Testing Growth Trends
• 5.3 Acquisition, License Agreements, Internal Development and Partnerships
• 5.4 Product Testing Depth in Mammography
• 5.5 Government Regulation
  • 5.5.1 U.S. Regulation
    • 5.5.1.1 Importing Medical Devices into the U.S.
    • 5.5.1.2 Exporting Medical Devices from the U.S.
  • 5.5.2 U.K. Regulation
  • 5.5.3 E.U. Regulation
  • 5.5.4 Japanese Regulation
• 5.6 Increased Market Penetration

6. Important Technology Trends

• 6.1 Stereoscopic Digital Mammography (SDM)
• 6.2 Magnetic resonance imaging (MRI)
• 6.3 Mammography Trends
• 6.4 Computer-Aided Detection (CAD)
• 6.5 Laser Image Development

7. Company Profiles

• 7.1 Agfa-Gevaert Corporation
• 7.2 Carestream Health
• 7.3 CMT Medical Systems
• 7.4 Fischer Imaging (Acquired by Hologic)
• 7.5 FujiFilm Medical Systems
• 7.6 General Electric Healthcare
• 7.7 Hitachi Medical Systems America, Inc.
• 7.8 Hologic Inc.
• 7.9 iCAD, Inc.
• 7.10 Imaging Diagnostic Systems Inc.
• 7.11 Philips Medical Systems
• 7.12 R2 Technology, Inc (Acquired by Hologic)
• 7.13 Scanis Inc.
• 7.14 Sectra Imtec AB
• 7.15 Siemens Healthcare
• 7.16 Toshiba America Medical Systems
• 7.17 Vidar Systems Corp.

8 .Appendices

• 8.1 Digital Database for Screening Mammography (DDSM)
• 8.2 Sources of National Cancer Institute Information
• 8.3 Screening Mammograms: Questions and Answers
• 8.4 FDA Rule: State Certification of Mammography Facilities

INDEX OF FIGURES

• Figure 2.1: Worldwide Annual Percent Increase in Imaging Market Size, 2002-2012
• Figure 2.2: U.S. Annual Percent Increase in Imaging Market Size, 2002-2012
• Figure 2.3: Total Spending on Healthcare in the U.S., 1960-2007
• Figure 2.4: International Per Capita Healthcare Spending by Country, 2006
• Figure 2.5: Number Uninsured and Uninsured Rate in the U.S., 1987-2006
• Figure 2.6: Global Market Share of Contrast Media Markets, 2006
• Figure 2.7: Worldwide Market Share of Medical Imaging and Diagnostic Companies, 2006
• Figure 3.1: Worldwide Market for Mammography Systems by Region, 2007
• Figure 3.2: Worldwide Market for Digital Mammography Systems by Region, 2007

INDEX OF TABLES

• Table 2.1: Global Medical Imaging Market Size, 2001-2012
• Table 2.2: U.S. Medical Imaging Market Size, 2001-2012
• Table 2.3: U.S. User Expenditures for Medical Imaging Equipment and Related Products, 2000-2007
• Table 2.4: Millions of Americans Over 65 Years of Age, 2000-2050
• Table 2.5: Insured and Uninsured Breakdown in the U.S., 2001-2005
• Table 2.6: Percentage of Population Without Health Insurance in the U.S., 2007
• Table 2.7: Total Number of U.S. Hospitals, 2007
• Table 2.8: U.S. Radiological Images Taken, 1999-2010
• Table 2.9: Global Market Share of Contrast Media Markets, 2006
• Table 2.10: Worldwide Market Share of Medical Imaging and Diagnostic Companies, 2006
• Table 2.11: Worldwide Imaging Procedures, 2001 to 2012
• Table 3.1: U.S. Use of Mammography in Women Over 40, 1987-2005
• Table 3.2: Annual Mammography Procedures in the U.S., 2000-2008
• Table 3.3: Annual Mammography Procedures in Europe, 2002-2007
• Table 3.4: Annual Mammography Procedures in Japan, 2002-2007
• Table 3.5: Annual Mammography Procedures in the Rest of the World, 2002-2007
• Table 3.6: Mammography Facts (U.S.), 2005
• Table 3.7: Breast Cancer Survival Rates by Country
• Table 3.8: Surgical Biopsies Performed in the U.S., 2000-2007
• Table 3.9: The Worldwide Mammography Instrument Market, 2000-2010
• Table 3.10: Worldwide Mammography Instrumentation Placements, 2002-2010
• Table 3.11: Worldwide Film-based Mammography Instrumentation Placements, 2002-2010
• Table 3.12: Worldwide Mammography Film-based Instrument Market, 2000-2010
• Table 3.13: Worldwide Mammography Film-based Instrument Market by Region, 2000-2010
• Table 3.14: U.S. Mammography Film-based Instrument Market, 2000-2010
• Table 3.15: U.S. Mammography Film-based Instrument Market Manufacturer Share, 2007
• Table 3.16: U.S. Film-based Mammography Instrumentation Placements, 2002-2010
• Table 3.17: European Mammography Film-based Instrument Market, 2000-2010
• Table 3.18: European Film-based Mammography Instrumentation Placements, 2002-2010
• Table 3.19: European Mammography Film-based Instrument Market Manufacturer Share, 2007
• Table 3.20: Japanese Mammography Film-based Instrument Market, 2000-2010
• Table 3.21: Japanese Film-based Mammography Instrumentation Placements, 2002-2010
• Table 3.22: Japanese Mammography Film-based Instrument Market Manufacturer Share
• Table 3.23: ROW Mammography Film-based Instrument Market, 2000-2010
• Table 3.24: ROW Film-based Mammography Instrumentation Placements, 2002-2010
• Table 3.25: Advantages of Digital Mammography
• Table 3.26: Worldwide Digital General Radiography Market, 2000-2012
• Table 3.27: Worldwide Market for Digital Mammography Systems Annual Unit Sales 2000-2010
• Table 3.28: Worldwide Market for Digital Mammography Systems Dollar Volume 2000-2010
• Table 3.29: Worldwide Mammography Digital Instrumentation Placements, 2002-2010
• Table 3.30: Worldwide Mammography Digital Instrument Market by Region, 2000-2010
• Table 3.31: Share of Worldwide Market for Digital Mammography Systems by Competitor, 2007
• Table 3.32: U.S. Mammography Digital Instrument Market, 2001-2010
• Table 3.33: U.S. Digital Mammography Instrumentation Placements, 2002-2010
• Table 3.34: European Mammography Digital Instrument Market, 2001-2010
• Table 3.35: European Digital Mammography Instrumentation Placements, 2002-2010
• Table 3.36: Japanese Mammography Digital Instrument Market, 2001-2010
• Table 3.37: Japanese Digital Mammography Instrumentation Placements, 2002-2010
• Table 4.1: Medicare Reimbursement for Mammography Services, 2007
• Table 6.1: CAD Mammography Systems

Medical Imaging Markets

1. Overview

• 1.1 Statement of Report
• 1.2 Scope of this Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Overview of the Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
  • 2.1.1 World Medical Imaging Market
  • 2.1.2 U.S. Medical Imaging Market
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiologic Services
  • 2.2.5 Overview of Medical Imaging Market Segments
  • 2.2.6 Market Drivers
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for Medical Imaging
• 2.3 Contrast Media
  • 2.3.1 Market Share
  • 2.3.2 Market Drivers
• 2.4 Picture Archiving and Communication Systems
  • 2.4.1 Picture Archiving and Communication Systems and Radiology Information Systems
  • 2.4.2 Increasing Digitization of Cardiology Image Storage and Management Creates Market Growth Opportunities
  • 2.4.3 Enterprise-Wide Integration is an Important Area for Future Market Development
  • 2.4.4 Competition Among Large Companies Intensifies
  • 2.4.5 Digital Imaging Technology Platforms
• 2.5 Medical Imaging Companies
  • 2.5.1 A Few Firms Dominate the Industry
• 2.6 Medical Imaging Industry Forecasts
• 2.7 Market Niches and Digitalization
• 2.8 Digital Imaging Techniques
  • 2.8.1 Clinical Uses
  • 2.8.2 Product Enhancements Drive Adoption of Imaging Devices Among End-Users
  • 2.8.3 Rapid Pace of Innovation Narrows Product Life Cycles and Restricts Spending
  • 2.8.4 Current and New Digital Imaging Procedures
  • 2.8.5 The Digital Impact on Clinical Imaging Markets
  • 2.8.6 Trends in Digital Imaging
  • 2.8.7 Enhancing Computed Radiography
  • 2.8.8 Digital Radiography versus Computed Radiography
  • 2.8.9 Digital Radiography Products

3. Digital Radiography Markets

• 3.1 Market Overview
• 3.2 Disadvantages of Film Technology
• 3.3 Computed Radiography and Direct-to-Digital Radiography Systems
• 3.4 Digital Radiography Market Trends
• 3.5 Market Segmentation
• 3.6 Digital Radiography Market Drivers
• 3.7 Market Restraints
• 3.8 Radiography Market Forecasts
  • 3.8.1 Revenue Forecasts
• 3.9 Competition
• 3.10 X-Ray Film Market Share
• 3.11 Installed Base and Procedure Forecasts
• 3.12 Digital Radiography Technology Platforms
  • 3.12.1 Digital Radiography Infrastructure
  • 3.12.2 Volume Levels
  • 3.12.3 Vendor Choice
  • 3.12.4 Computed Radiography versus Digital Radiography
  • 3.12.5 Vendor/Customer Consultation
  • 3.12.6 Enhancing Computed Radiography
  • 3.12.7 Digital Radiography Technology
  • 3.12.8 Charge-Coupled Devices
  • 3.12.9 Slot Scan
  • 3.12.10 Tiled CCD Arrays
  • 3.12.11 Direct Conversion
  • 3.12.12 Direct versus Indirect Detection Technology
  • 3.12.13 Flat-Panel Indirect Detectors
  • 3.12.14 Flat-Panel Direct Detectors
  • 3.12.15 Picture Archiving and Communication Systems
  • 3.12.16 PACS Units Versus CCD Units
  • 3.12.17 Fluoroscopy
• 3.13 Types of Digital X-Ray Imaging
  • 3.13.1 The Benefits of Digital X-Ray
  • 3.13.2 Image Intensifier/TV Systems
  • 3.13.3 CR Technology Platforms
  • 3.13.4 Charge-Coupled Devices
  • 3.13.5 Scintillator with Photodiode Array
  • 3.13.6 Direct Capture Using Flat-Panel Detectors
• 3.14 Digital Radiography Applications
  • 3.14.1 Three-Dimensional Imaging
  • 3.14.2 Cardiovascular Imaging
• 3.15 Market Factors
  • 3.15.1 Portable DR Systems
  • 3.15.2 Software and Advanced Applications
• 3.16 Products
  • 3.16.1 Agfa
  • 3.16.2 Analogic
  • 3.16.3 Carestream Health, Inc.
  • 3.16.4 Canon Medical Systems
  • 3.16.5 Fuji Medical Systems
  • 3.16.6 Fischer Medical Technologies
  • 3.16.7 GE Healthcare
  • 3.16.8 Imaging Dynamics
  • 3.16.9 InfiMed
  • 3.16.10 Konica Minolta Medical Imaging
  • 3.16.11 Philips Healthcare
  • 3.16.12 Precise Optics
  • 3.16.13 Quantum Medical Imaging
  • 3.16.14 Siemens Medical Solutions
  • 3.16.15 Shimadzu Medical Systems
  • 3.16.16 Toshiba America Medical Systems
  • 3.16.17 Stallion Technologies
  • 3.16.18 Swissray International
  • 3.16.19 Trixell SAS
  • 3.16.20 Varian Medical Systems
• 3.17 Manufacturers

4. Mammography

• 4.1 Mammography Overview
• 4.2 Breast Cancer
• 4.3 Film-based Mammography Market
  • 4.3.1 Market Overview
  • 4.3.2 Market Drivers
  • 4.3.3 Market Restraints
  • 4.3.4 Film-based Mammography Market and Technology Trends
  • 4.3.5 U.S. Market for Film-based Screening Systems
  • 4.3.6 European Market for Film-based Mammography Systems
• 4.4 Digital Mammography
  • 4.4.1 Digital Mammography Offers Attractive Operation Costs/Ownership Benefits
• 4.5 Digital versus Standard Mammography
• 4.6 Digital Mammography Markets
  • 4.6.1 Structure Unit Sales and Revenue
• 4.7 World Mammography Markets Revenue
  • 4.7.1 Unit Shipment and Revenue Forecasts
  • 4.7.2 Market Share
  • 4.7.3 Digital Mammography Placements
  • 4.7.4 Competitive Structure
  • 4.7.5 New Technologies and Features Essential for Future Growth
• 4.8 Digital X-Ray Mammography Technology Analysis
  • 4.8.1 Product Background
  • 4.8.2 Market Drivers
  • 4.8.3 Market Restraints
  • 4.8.4 Technological Solutions
  • 4.8.5 Competitive Analysis
  • 4.8.6 U.S. Installed Base Analysis
• 4.9 Trends in Digital X-Ray Imaging Markets
• 4.10 Types of Mammography Imaging
  • 4.10.1 Stereoscopic Digital Mammography
  • 4.10.2 Magnetic Resonance Imaging
  • 4.10.3 Computer-Aided Detection
• 4.11 Products
  • 4.11.1 Agfa-Gevaert Corporation
  • 4.11.2 Carestream Health
  • 4.11.3 CMT Medical Systems
  • 4.11.4 Fujifilm Medical Systems
  • 4.11.5 GE Healthcare
  • 4.11.6 Hologic
  • 4.11.7 Imaging Diagnostic Systems
  • 4.11.8 Sectra
  • 4.11.9 Siemens Medical Solutions
• 4.12 Manufacturers

5. Computed Tomography Market

• 5.1 Overview
• 5.2 Market Measurements
  • 5.2.1 Market Drivers
  • 5.2.2 Market Restraints
• 5.3 CT Market Forecasts
  • 5.3.1 U.S. Revenue Forecasts
  • 5.3.2 Single-Slice Computed Tomography
  • 5.3.3 Multi-slice Computed Tomography
  • 5.3.4 U.S. Competitive Structure
  • 5.3.5 European Market Revenue Forecasts
  • 5.3.6 European Competitive Structure
• 5.4 CT Technology Platforms
  • 5.4.1 Fan-Beam
  • 5.4.2 Cone-Beam
  • 5.4.3 Multi-Slice Scanners
• 5.5 CT Market Trends
  • 5.5.1 Market Segmentation
• 5.6 Digital CT Applications
  • 5.6.1 Introduction
  • 5.6.2 Cardiac CT and EBT Scanner Forecasts and Trends
  • 5.6.3 Other Applications
• 5.7 Market Factors
• 5.8 Contrast Media
  • 5.8.1 Revenue Forecasts
• 5.9 Products
  • 5.9.1 Shimadzu
  • 5.9.2 Toshiba America Medical Systems
  • 5.9.3 Siemens
  • 5.9.4 GE Healthcare
  • 5.9.5 Philips Healthcare
  • 5.9.6 Others
• 5.10 Manufacturers

6. Magnetic Resonance Market

• 6.1 MRI Overview
  • 6.1.1 Market Segmentation and Definitions: MRI Market
• 6.2 Market Measurements
  • 6.2.1 Market Drivers for Open and Closed MRI Segments
• 6.3 Market Restraints for Open and Closed MRI Segments
• 6.4 Market Drivers for Low-/Mid-/High-Field MRI Segments
• 6.5 Market Restraints for Low-/Mid-/High-Field MRI Segments
• 6.6 Revenue Forecasts
• 6.7 Procedure Forecast
  • 6.7.1 Breast Imaging
  • 6.7.2 Cardiac Imaging
  • 6.7.3 Orthopedic Imaging
  • 6.7.4 Functional MRI
  • 6.7.5 The Angiography Alternative
  • 6.7.6 More Directions for Magnetic Resonance Imaging
  • 6.7.7 Buying and Selling MRI Market Dynamics
• 6.8 Competitive Structure: Open and Closed Magnetic Resonance Imaging
• 6.9 Competitive Structure: Low-/Mid-/High-Field Magnetic Resonance Imaging
• 6.10 Market Analysis
• 6.11 Contrast Media
  • 6.11.1 Revenue Forecasts
• 6.12 Products
  • 6.12.1 Covidien/Mallinckrodt
  • 6.12.2 ETS-Lindgren
  • 6.12.3 Fonar Corporation
  • 6.12.4 GE Healthcare
  • 6.12.5 Hitachi Medical Systems America
  • 6.12.6 Machnet BV
  • 6.12.7 Medis Medical Imaging Systems BV
  • 6.12.8 Mednovus, Inc.
  • 6.12.9 ONI Medical Systems
  • 6.12.10 Philips Healthcare
  • 6.12.11 Siemens Medical Solutions
  • 6.12.12 Toshiba America Medical Systems
• 6.13 Manufacturers

7. Ultrasound Market

• 7.1 Ultrasound Market Trends
  • 7.1.1 Overview
  • 7.1.2 Market Segmentation and Definitions
  • 7.1.3 Market Developments
  • 7.1.4 Market Drivers
  • 7.1.5 Market Restraints
• 7.2 Ultrasound Market Forecasts
  • 7.2.1 Revenue Forecasts
  • 7.2.2 Unit Shipment Forecasts
  • 7.2.3 Installed Base Forecast
  • 7.2.4 Competitive Structure
  • 7.2.5 Market Analysis
• 7.3 Cardiology Ultrasound Segment Forecasts
  • 7.3.1 Revenue Forecasts
  • 7.3.2 Unit Shipment Forecasts
  • 7.3.3 Market Share Analysis
• 7.4 OB/GYN Ultrasound Segment Forecasts
• 7.5 Radiology Ultrasound Segment Forecasts
• 7.6 Handheld Ultrasound Segment Forecasts
  • 7.6.1 Revenue Forecasts
  • 7.6.2 Market Share Analysis
• 7.7 Contrast Media
  • 7.7.1 Revenue Forecasts
  • 7.7.2 Market Share Analysis
• 7.8 New Transducer Technology
• 7.9 Intravascular Ultrasound
• 7.10 Products
  • 7.10.1 Ardent Sound
  • 7.10.2 CIVCO Medical Instruments
  • 7.10.3 GE Healthcare
  • 7.10.4 Medison Co. Ltd.
  • 7.10.5 Mindray Co. Ltd.
  • 7.10.6 Philips Healthcare
  • 7.10.7 Sea Ridge Software
  • 7.10.8 Siemens Medical Solutions
  • 7.10.9 Sony Medical Products
  • 7.10.10 SonoSite Inc.
  • 7.10.11 TeraRecon
  • 7.10.12 Toshiba America Medical Systems
  • 7.10.13 U-Systems
  • 7.10.14 ZONARE Medical Systems
• 7.11 Manufacturers

8 .Nuclear Imaging Market

• 8.1 Market Overview
• 8.2 Market Segmentation and Definitions
• 8.3 Market Trends
• 8.4 Market Drivers
• 8.5 Market Restraints
• 8.6 Gamma Camera Market Forecasts
  • 8.6.1 Revenue Forecasts
• 8.7 Competition
• 8.8 Market Share
• 8.9 Market Factors
• 8.10 Installed Base and Procedure Forecasts
• 8.11 Gamma Camera Technology Platforms
  • 8.11.1 Single Photon Emission Computed Tomography
  • 8.11.2 Attenuation Correction Technology
  • 8.11.3 Charge-Coupled Devices
  • 8.11.4 Flat-Panel Indirect Detectors
  • 8.11.5 Flat-Panel Direct Detectors
  • 8.11.6 Picture Archiving and Communication Systems
  • 8.11.7 Laser versus Charge-Coupled Devices
• 8.12 Types of Gamma Camera Imaging
  • 8.12.1 Image Intensifier/Television Systems
  • 8.12.2 Scintillator with Photodiode Array
• 8.13 Gamma Camera Applications
  • 8.13.1 Prostate Cancer
  • 8.13.2 Scintimammography
  • 8.13.3 Cardiovascular Imaging
• 8.14 PET Market
  • 8.14.1 Total PET and PET/CT Market Trends
  • 8.14.2 Total PET and PET/CT Market Forecasts
  • 8.14.3 Stand-Alone PET Market Forecasts
  • 8.14.4 PET/CT Market Forecasts
• 8.15 Products
  • 8.15.1 Eurorad-Euromedical
  • 8.15.2 Gamma Medica
  • 8.15.3 GE Healthcare
  • 8.15.4 Naviscan PET Systems
  • 8.15.5 Philips Healthcare
  • 8.15.6 Toshiba America Medical Systems
  • 8.15.7 Siemens Medical Solutions
• 8.16 Manufacturers

9. PACS Markets

• 9.1 PACS Market Trends
  • 9.1.1 Market Segmentation and Definitions
  • 9.1.2 Overview
  • 9.1.3 Market Measurements
  • 9.1.4 Market Drivers
  • 9.1.5 Market Restraints
• 9.2 PACS Market Forecasts
  • 9.2.1 Revenue Forecasts
  • 9.2.2 Installed Base and Penetration Forecasts
  • 9.2.3 Competitive Structure
  • 9.2.4 Market Share Analysis
• 9.3 PACS Software and Services
• 9.4 PACS Hardware Solutions
  • 9.4.1 RIS/PACS Revenue Forecasts
• 9.5 Products
  • 9.5.1 Carestream Health Inc.
  • 9.5.2 Cedara Software
  • 9.5.3 DeJarnette Research Systems
  • 9.5.4 Fujifilm Medical Systems USA
  • 9.5.5 GE Healthcare (RIS/PACS)
  • 9.5.6 IMCO Technologies
  • 9.5.7 Infinitt North America
  • 9.5.8 Intelerad Medical Systems, Inc.
  • 9.5.9 Intuitive Imaging Informatics, LLC
  • 9.5.10 McKesson Corporation
  • 9.5.11 Merge Healthcare
  • 9.5.12 MIMvista Corp.
  • 9.5.13 NovaRad Corp.
  • 9.5.14 Philips Healthcare (PACS)
  • 9.5.15 ODS Medical
  • 9.5.16 RamSoft, Inc.
  • 9.5.17 ScImage
  • 9.5.18 Sectra Imtec AB
  • 9.5.19 Siemens Medical Solutions (RIS/PACS)
  • 9.5.20 Thinking Systems Corporation
• 9.6 Manufacturers

10. Three-Dimensional Imaging Markets

• 10.1 Total 3D Imaging Market Trends
  • 10.1.1 Overview
  • 10.1.2 Market Drivers
  • 10.1.3 Market Restraints
• 10.2 Total 3D Imaging Market Forecasts
• 10.3 Three-Dimensional CT/MRI/Angiography Market Forecasts
• 10.4 Three-Dimensional Ultrasound Imaging Market Forecasts
• 10.5 Products
• 10.6 Manufacturers

11. Emerging Technologies and Products

• 11.1 Global Picture Archiving and Communication Systems
• 11.2 Image Processing
• 11.3 Magnetic Resonance Imaging
• 11.4 Computed Tomography for Calcium Scoring
• 11.5 Myocardial Perfusion Imaging
• 11.6 Real-time Three-Dimensional Scanning
• 11.7 Optical Imaging

12. Products by Modality

• 12.1 Comparing Modalities
• 12.2 Magnetic Resonance Imaging
• 12.3 Computed Tomography
• 12.4 Mammography
• 12.5 Digital Mammography
• 12.6 Positron Emission Tomography
• 12.7 Reimbursement
• 12.8 X-Ray
• 12.9 Vascular X-Ray
• 12.10 Digital Modalities
• 12.11 Digital Benefits

13. Market Analysis by Modality

• 13.1 Magnetic Resonance Imaging
  • 13.1.1 Products
• 13.2 Computed Tomography
  • 13.2.1 Products
• 13.3 Nuclear Medicine
  • 13.3.1 Products
• 13.4 X-Ray
  • 13.4.1 Products
• 13.5 Digital Mammography
  • 13.5.1 Products

14. Business Trends in the Industry

• 14.1 Sector Consolidation
• 14.2 Medical Imaging Growth Trends
• 14.3 Mergers and Acquisitions
  • 14.3.1 Center for Diagnostic Imaging Signs With Medicalis
  • 14.3.2 HealthSouth Sells Diagnostic Division to The Gores Group
  • 14.3.3 AMICAS Acquires Technology Partners' Practice Management Software
  • 14.3.4 MDS Nordion and Avid Radiopharmaceuticals Enter Collaboration
  • 14.3.5 NightHawk Radiology Holdings Acquires Teleradiology Diagnostic Service
  • 14.3.6 Siemens Acquires German HIS Company
  • 14.3.7 Siemens Medical Finalizes Acquisition of Bayer' s Diagnostics Division
  • 14.3.8 GE Healthcare Acquires Dynamic Imaging
  • 14.3.9 Hologic Acquires BioLucent
• 14.4 Product Testing Depth in Medical Imaging Testing
• 14.5 Government Regulation
  • 14.5.1 U.S. Regulation
  • 14.5.2 U.K. Regulation
  • 14.5.3 E.U. Regulation
  • 14.5.4 Japanese Regulation

15. Company Profiles

• 15.1 Agfa-Gevaert Corp.
• 15.2 Analogic Corp.
• 15.3 Canon
• 15.4 Carestream Health, Inc.
• 15.5 CMT Medical Technologies
• 15.6 Confirma, Inc.
• 15.7 DALSA
• 15.8 Del Medical Systems
• 15.9 Fonar Corp.
• 15.10 Fujifilm Medical Systems USA
• 15.11 GE Healthcare
• 15.12 Hitachi Medical Systems America, Inc.
• 15.13 Hologic, Inc.
• 15.14 iCAD, Inc.
• 15.15 Imaging Diagnostic Systems, Inc.
• 15.16 IMIX
• 15.17 InfiMed, Inc.
• 15.18 Medison Co., Ltd.
• 15.19 Philips Healthcare
• 15.20 Scanis Inc.
• 15.21 Sectra
• 15.22 Schick Technologies, Inc.
• 15.23 Siemens Healthcare
• 15.24 Swissray International
• 15.25 Toshiba America Medical Systems
• 15.26 Trixell SAS
• 15.27 Varian Medical Systems, Inc.
• 15.28 Vidar Sytems Corp.

16. Appendices

• 16.1 Digital Database for Screening Mammography
• 16.2 Sources of National Cancer Institute Information
• 16.3 Screening Mammograms: Questions and Answers
• 16.4 FDA Rule: State Certification of Mammography Facilities

LIST OF FIGURES

• Figure 2.1: Total Spending on Healthcare in the U.S., 1960-2007
• Figure 2.2: International Per Capita Per Country, 2006

LIST OF TABLES

• Table 2.1: Global Medical Imaging Market Size, 2001-2013
• Table 2.2: U.S. Medical Imaging Market Size, 2001-2013
• Table 2.3: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 2.4: Millions of Americans Over 65 Years of Age, 2000-2050
• Table 2.5: Hospital Survey, 2007
• Table 2.6: U.S. Radiological Images Taken, 1999-2010
• Table 2.7: Market Share of Contrast Media Markets, 2008
• Table 2.8: Worldwide Market Share Medical Imaging and Diagnostic Companies, 2008
• Table 2.9: Worldwide Imaging Procedures, 2001-2013
• Table 3.1: World Market for Digital General Radiography Systems, 2000-2013
• Table 3.2: U.S. Digital Radiography Unit Sales, 2002-2013
• Table 3.3: X-Ray Film Market Segment by Brand, U.S. Market Share, 2008
• Table 3.4: Average Examination Times: Cassette-Based Computed Radiography versus Digital Radiography
• Table 3.5: Manufacturers of CCD-Based Digital Radiography Systems
• Table 4.1: U.S. Use of Mammography in Women Aged 40 and Over, 2000-2005
• Table 4.2: Annual Mammography Procedures in the U.S., 2000-2008
• Table 4.3: Annual Mammography Procedures in Europe, 2002-2007
• Table 4.4: Annual Mammography Procedures in Japan, 2002-2008
• Table 4.5: Breast Cancer Survival Rates by Country
• Table 4.6: Surgical Biopsies Performed in the U.S., 2000-2008
• Table 4.7: Worldwide Mammography Film-based Instrument Market, 2000-2010
• Table 4.8: Worldwide Mammography Film-based Instrument Market by Region, 2000-2010
• Table 4.9: U.S. Mammography Film-based Instrument Market, 2000-2010
• Table 4.10: U.S. Mammography Film-based Instrument Market Manufacturer Share, 2008
• Table 4.11: European Mammography Film-based Instrument Market, 2000-2010
• Table 4.12: Worldwide Market for Digital Mammography Systems, Annual Unit Sales, 2000-2012
• Table 4.13: Worldwide Market for Digital Mammography Systems, 2000-2012
• Table 4.14: U.S. Mammography Digital Instrument Market, 2001-2012
• Table 4.15: Share of Worldwide Market for Digital Mammography Systems by Competitor, 2008
• Table 4.16: The Worldwide Mammography Instrument Market, 2000-2010
• Table 4.17: Worldwide Digital Mammography Instrumentation Placements, 2002-2010
• Table 4.18: U.S. Digital Mammography Instrumentation Placements, 2002-2010
• Table 4.19: CAD Mammography Systems
• Table 5.1: U.S. CT Scans per Year, 2001-2010
• Table 5.2: U.S. Market for CT Scanners, 2001-2013
• Table 5.3: U.S. Market for Single-Slice CT Scanners, 2001-2010
• Table 5.4: European Market for CT Scanners, 2006-2013
• Table 5.5: CT Contrast Media Market Size and Growth, 2000-2013
• Table 6.1: U.S. MRI Scans per Year, 2001-2012
• Table 6.2: The High-Field (1T and Up) MRI Market, 2001-2012
• Table 6.3: The Mid-Field (0.5T to 0.9T) MRI Market, 2001-2012
• Table 6.4: The Low-Field (Below 0.5T) MRI Market, 2001-2012
• Table 6.5: MRI Contrast Media Market Size and Growth, 2000-2012
• Table 7.1: Worldwide Ultrasound Procedures, 2000-2012
• Table 7.2: Worldwide Sales of Ultrasound Equipment, 2000-2012
• Table 7.3: U.S. Sales of Ultrasound Equipment, 2000-2012
• Table 7.4: Worldwide Cardiology Ultrasound Procedures, 2000-2012
• Table 7.5: Worldwide Sales of Cardiology Ultrasound Equipment, 2000-2012
• Table 7.6: U.S. Sales of Cardiology Ultrasound Equipment, 2000-2012
• Table 7.7: U.S. Sales of Handheld Ultrasound Equipment, 2000-2012
• Table 7.8: Worldwide Sales of Ultrasound Contrast Agents, 1999-2012
• Table 8.1: World Radiopharmaceutical Scans, 2001-2010
• Table 8.2: World Market for Gamma Camera Scans, 2002-2012
• Table 8.3: Worldwide Dollar Sales of PET Imaging Systems, 2004-2012
• Table 8.4: U.S. Dollar Sales of PET Imaging Systems, 2004-2012
• Table 8.5: Unit Sales of PET Imaging Systems, U.S. and Worldwide, 2004-2012
• Table 8.6: Installed Base of PET Imaging Systems, 2004-2012
• Table 8.7: PET Procedure Volume, 2004-2012
• Table 8.8: FDG Sales, 2004-2012
• Table 8.9: Unit Sales of PET Imaging Systems, U.S. and Worldwide, 2004-2012
• Table 8.10: U.S. PET/CT Scanner Market Size and Growth, 2002-2012
• Table 9.1: U.S. Market for PACS, 2005-2012
• Table 9.2: Penetration Rates of PACS in U.S. Hospitals, 2006-2012
• Table 13.1: World Medical Diagnostic Market for CT Systems, 2002-2012
• Table 13.2: U.S. Medical Diagnostic Market for CT Systems, 2002-2012
• Table 13.3: World Medical Diagnostic Market for Nuclear Medicine, 2002-2012
• Table 13.4: U.S. Medical Diagnostic Market for Nuclear Medicine, 2002-2012
• Table 13.5: World Medical Diagnostic Market for X-Ray Systems, 2002-2012
• Table 13.6: U.S. Medical Diagnostic Market for Analog X-Ray Systems, 2002-2012
• Table 13.7: World Medical Diagnostic Market for Digital X-Ray Systems, 2002-2012

Nuclear Cardiology Markets

1. Overview

• 1.1 Objectives
• 1.2 Scope
• 1.3 Methodology
• 1.4 Executive Summary

2. Medical Imaging Market Analysis

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiology Services
  • 2.2.5 Medical Imaging Companies
  • 2.2.6 Market Drivers
    • 2.2.6.1 Product Enhancements
    • 2.2.6.2 Contrast Agents Development
    • 2.2.6.3 Innovation
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for Medical Imaging
    • 2.2.8.1 Discovery
    • 2.2.8.2 Clinical Applications
    • 2.2.8.3 Clinical Trials
    • 2.2.8.4 Outpatient Facilities
    • 2.2.8.5 Technology Advances in Diagnostic Imaging Modalities
    • 2.2.8.6 Safety and Ergonomics Concerns
    • 2.2.8.7 Volumetric Imaging
    • 2.2.8.8 Digital Radiography (DR)
    • 2.2.8.9 Contrast Media

3. Nuclear Medicine and Nuclear Cardiology Market

• 3.1 Medical Imaging Industry Forecasts
• 3.2 Hardware Companies (Nuclear Medicine Instrumentation)
• 3.3 Software Companies (Image Processing and PACS)
• 3.4 Radiopharmaceuticals and Pharmaceuticals Companies
• 3.5 Ancillary Products Companies
• 3.6 Service and Support Companies
• 3.7 Nuclear Cardiology Market
• 3.8 Hardware (PET, SPECT and Hybrids)
  • 3.8.1 Scanner Investment: Not Just a Cardiology Market
    • 3.8.1.1 Impact of Alzheimer' s Reimbursement
  • 3.8.2 Sales Trends for PET Scanners
  • 3.8.3 Market Consolidation in the U.S.
  • 3.8.4 Learning Curve Impact for PET
  • 3.8.5 Hardware Market Trends
• 3.9 Software (PACS and RIS)
• 3.10 Radiopharmaceuticals
  • 3.10.1 Diagnostic Radiopharmaceuticals
  • 3.10.2 Therapeutic Radiopharmaceuticals

4. Products Analysis

• 4.1 Nuclear Medicine Instrumentation
  • 4.1.1 PET Scan
  • 4.1.2 SPECT Scan
    • 4.1.2.1 Heart Imaging
  • 4.1.3 PET Versus SPECT
  • 4.1.4 Hybrid Technology
• 4.2 Image Processing: PACS
  • 4.2.1 PACS and Nuclear Medicine
  • 4.2.2 Difficulties in Making PACS Work with Nuclear Medicine
    • 4.2.1.2 3-D and Quantitative Analysis
    • 4.2.1.5 Small Market Opportunities
• 4.3 Radiopharmaceuticals and Pharmaceuticals
  • 4.3.1 Introduction
  • 4.3.2 Background
  • 4.3.3 Areas of Current Interest

5. Regulations, Reimbursements and Other Issues

• 5.1 Food and Drug Administration (FDA)
  • 5.1.1 FDA Guidance
  • 5.1.2 FDA Nuclear Medicine Coalition
• 5.2 U.S. Nuclear Regulatory Commission (NRC)
  • 5.2.1 What NRC Regulates
  • 5.2.2 How NRC Regulates
  • 5.2.3 Related Information
• 5.3 Memorandum of Understanding between NRC and FDA
  • 5.3.1 Authorities and Regulatory Programs
• 5.4 Current NRC Issues and Actions
  • 5.4.1 Meetings
  • 5.4.2 Program and Policy Issues
  • 5.4.3 Recently Issued Significant Enforcement Actions
    • 5.4.3.1 Stark II Regulations
    • 5.4.3.2 Recent Impact of Stark II Regulations
    • 5.4.3.3 Reimbursement

6. Business Affairs (Mergers, Acquisitions and Partnerships)

• 6.1 Recent Corporate Partnerships and Mergers
• 6.2 Recent Industry Activity
• 6.3 Product Launches and Developments

7. Technology Trends

• 7.1 Hardware (Nuclear Medicine Instrumentation)
• 7.2 Software (PACS)
  • 7.2.1 Problems Interfacing PACS and NM
  • 7.2.2 SNM and IHE
  • 7.2.3 IHE Nuclear Medicine Profile
  • 7.2.4 What Next?
  • 7.2.5 Optimal Patient Care
  • 7.2.6 Four Steps to Standards Adoption
  • 7.2.7 Technical Framework: Business with Technology
  • 7.2.8 Leading by Example
  • 7.2.9 IHE and Electronic Health Record (EHR)
• 7.3 Radiopharmaceuticals and Pharmaceuticals
  • 7.3.1 Market Share
  • 7.3.2 Contrast Media Market Drivers
  • 7.3.3 Contrast Media Market Sector Overview
  • 7.3.4 Contrast Media Market Analysis
  • 7.3.5 Growth Prospects for Contrast Media
• 7.4 Market Sector Analysis
• 7.5 Leading Companies in General Medical Imaging

8. Company Profiles

• 8.1 Hardware (Nuclear Medicine Instrumentation)
  • 8.1.1 AccuSync Medical Research
  • 8.1.2 Bristol-Myers Squibb (Medical Imaging)
  • 8.1.3 Capintec
  • 8.1.4 CardiArc
  • 8.1.5 Cardinal Health (Cardiology Solutions)
  • 8.1.6 Digirad
  • 8.1.7 GE Healthcare
  • 8.1.8 GVI Medical Devices
  • 8.1.9 Hitachi Medical Systems America
  • 8.1.10 IS2 Medical Systems
  • 8.1.11 Mediso
  • 8.1.12 Philips Medical
  • 8.1.13 Positron
  • 8.1.14 Siemens Medical
  • 8.1.15 Spectrum Dynamics
• 8.2 Software (Image Processing and PACS)
  • 8.2.1 Heartlab
  • 8.2.2 Hermes Medical Solutions
  • 8.2.3 INVIA
  • 8.2.4 McKesson
  • 8.2.5 MedImage
  • 8.2.6 MIMvista
  • 8.2.7 Numa
  • 8.2.8 ProSolv Cardiovascular
  • 8.2.9 Scientific Imaging
  • 8.2.10 Segami Corporation
  • 8.2.11 Syntermed
  • 8.2.12 Thinking Systems Corporation
  • 8.2.13 UltraSPECT
  • 8.2.14 Witt Biomedical Corporation
• 8.3 Radiopharmaceuticals and Pharmaceuticals
  • 8.3.1 Astellas Pharma U.S.
  • 8.3.2 Bracco Diagnostics
  • 8.3.3 Isotope Products Laboratories
  • 8.3.4 Izotop: Institute of Isotopes
  • 8.3.5 Mallinckrodt
  • 8.3.6 Merck
  • 8.3.7 NuView Radiopharmaceuticals
  • 8.3.8 Pfizer
  • 8.3.9 Tyco Healthcare
• 8.4 Ancillary Products
  • 8.4.1 CNMTStore.com
  • 8.4.2 Data Spectrum Corporation
  • 8.4.3 Daxor Corporation
  • 8.4.4 Ivy Biomedical Systems
  • 8.4.5 MarCal Medical
• 8.5 Service and Support
  • 8.5.1 BC Technical
  • 8.5.2 Diagnostix Plus
  • 8.5.3 MedAxiom
  • 8.5.4 MediNuclear Corporation (MNC)
  • 8.5.5 MEDX
  • 8.5.6 Pinestar Technology
  • 8.5.7 Technology Imaging Services
• 8.6 Other Business Opportunities

9. Other Elements of Nuclear Medicine Industry

• 9.1 Nuclear Medicine: Guidelines, Certification and Societies
  • 9.1.1 American College of Radiology (ACR)
  • 9.1.2 American Society of Nuclear Cardiology (ASNC)
  • 9.1.3 Associates in Medical Physics (AMP)
  • 9.1.4 Certification Board of Nuclear Cardiology (CBNC)
  • 9.1.5 ICANL
  • 9.1.6 IHE
  • 9.1.7 ISO
  • 9.1.8 MedPage Today
  • 9.1.9 Nuclear Medicine Technology Certification Board (NMTCB)
  • 9.1.10 Society of Cardiovascular Computed Tomography (SCCT)
  • 9.1.11 Society of Nuclear Medicine (SNM)
• 9.2 Nuclear Medicine: Publications
  • 9.2.1 Elsevier
  • 9.2.2 HRA Research
  • 9.2.3 Lippincott Williams & Wilkins

INDEX OF FIGURES

• Figure 3.1: U.S. Nuclear Imaging Procedures
• Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006
• Figure 4.1: Nuclear Imaging
• Figure 4.2: PET Scan
• Figure 4.3: SPECT Scan
• Figure 4.4: PET-CT Scan
• Figure 4.5: SPECT-CT Scan
• Figure 7.1: IHE Technical Framework
• Figure 7.2: IHE Framework Organization
• Figure 7.3: IHE Actors and Transactions

INDEX OF TABLES

• Table 2.1: U.S. Medical Imaging Market Size, 2001-2010
• Table 2.2: Global Medical Imaging Market Size, 2001-2010
• Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010
• Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050
• Table 2.6: Hospital Survey
• Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004
• Table 2.8: Worldwide Market Share of Medical Imaging Companies
• Table 2.9: Worldwide Imaging Procedures, 2001 to 2010
• Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities
• Table 7.1: Market Share of Contrast Media Players
• Table 7.2: Contrast Media Market Growth, 2003-2010
• Table 7.3: Worldwide Imaging Procedures, 2001-2010
• Table 8.1: Astellas Alliances

Picture Archiving and Communications Systems (PACS)

1. Overview

• 1.1 Statement of Report
• 1.2 About This Report
• 1.3 Scope of the Report
• 1.4 Objectives
• 1.5 Methodology
• 1.6 Executive Summary

2. The Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiology Services
  • 2.2.5 Medical Imaging Companies
  • 2.2.6 Market Drivers
    • 2.2.6.1 Product Enhancements Drive Adoption of Imaging Procedures Among End-Users
    • 2.2.6.2 Potential of Novel Contrast Agents Development to Drive Imaging Procedure Volumes
    • 2.2.6.3 Rapid Pace of Innovation Narrows Product Lifecycles and Restricts Spending
  • 2.2.7 Market Restraints
  • 2.2.8 Market Aspects
    • 2.2.8.1 Molecular Imaging
    • 2.2.8.2 Outpatient Facilities are the Best Growth Market
    • 2.2.8.3 Diagnostic Imaging Modalities Witness Several Technology Advancements
    • 2.2.8.4 Safety and Ergonomics Concerns Drive Technology Growth
    • 2.2.8.5 Volumetric Imaging and Post-Image Processing Techniques Develop Rapidly
    • 2.2.8.6 Increasing Implementation of PACS Units Pushes Digital Radiography into High Gear
    • 2.2.8.7 Future Price Reduction Set to Stimulate Wider Acceptance of DR Systems
    • 2.2.8.8 High-Performance Imaging Combined with Lower Radiation Doses Spurs DR Growth
• 2.3 Market Sector Analysis
  • 2.3.1 Competition
  • 2.3.2 Penetration Rates of PACS

3. PACS Market

• 3.1 PACS Technology
  • 3.1.1 PACS History
    • 3.1.1.1 In the Beginning
    • 3.1.1.2 PACS Pioneers
    • 3.1.1.3 Early Efforts
    • 3.1.1.4 Early PACS Efforts
    • 3.1.1.5 DICOM Begins
    • 3.1.1.6 Filmless
    • 3.1.1.7 Today and Tomorrow
  • 3.1.2 Image Acquisition
  • 3.1.3 Distribution and Communication
  • 3.1.4 Archiving
  • 3.1.5 Servers
  • 3.1.6 Image Display Systems
  • 3.1.7 PACS Drivers
  • 3.1.8 Barriers
• 3.2 PACS Vendors
• 3.3 Leading PACS Vendors
• 3.4 PACS Societies
• 3.5 PACS Forecasts
• 3.6 Market Dynamics
  • 3.6.1 Market Challenges
  • 3.6.2 Integrating Imaging Systems
  • 3.6.3 Lack of Funding can Stall Introduction of PACS
  • 3.6.4 Determining and Defining the Return on Investment (ROI) of PACS Solutions
  • 3.6.5 Effective PACS Training
  • 3.6.6 PACS Outside the Radiology Department and the Hospital
  • 3.6.7 Development of Web-based and GUI PACS Solutions
  • 3.6.8 How Much is Enough Storage?
  • 3.6.9 Information Lifecycle Management (ILM)
    • 3.6.9.1 The Process
    • 3.6.9.2 Automation
    • 3.6.9.3 Simplified Disaster Recovery
    • 3.6.9.4 Better Backups
    • 3.6.9.5 Solving the problem
  • 3.6.10 Always Online PACS
  • 3.6.11 Cost of Electronic Storage and Data Transfer Decreasing (Moore' s Law)
  • 3.6.12 Hospital CEOs and PACS
  • 3.6.13 PACS and RIS Integration Benefits
    • 3.6.13.1 Brokered Versus Integrated RIS/PACS
  • 3.6.14 The Healthcare Leadership Council Congressional Recommendations
  • 3.6.15 Deployment of Filmless Environments Attracting the Best Recruits
    • 3.6.15.1 Planning for Migration from One PACS to Another?
    • 3.6.15.2 Critical Success Factors as Seen by the Referring Physicians
    • 3.6.15.3 Connecting PACS to Results: Text and Images Together
    • 3.6.15.4 ROI on PACS and RIS
    • 3.6.15.5 Advantages of Outsourcing Digital Storage Rather than Implementing an Archive in House
    • 3.6.15.6 Special Considerations in PACS for Extensive Remote or Outsourced Image Reading
    • 3.6.15.7 Enhancing Workflow to Optimize Service to Emergency Medicine
    • 3.6.15.8 Customer Support for PACS: Guidelines
    • 3.6.15.9 RIS/PACS Target Outcomes and Benefit Realization
    • 3.6.15.10 How PACS Helps Radiology Deal with CR?
    • 3.6.15.11 Interfaced, Integrated and Unified PACS
• 3.7 PACS Usage
• 3.8 Purchase Options
  • 3.8.1 Turnkey
  • 3.8.2 Software-only PACS (Best of Breed/Unbundled Solutions)
  • 3.8.3 Web-based PACS
  • 3.8.4 Application Service Provider
• 3.9 Telemedicine/Teleradiology
  • 3.9.1 Opportunities
    • 3.9.1.1 Civilian
    • 3.9.1.2 Military
• 3.10 Software (Image Processing, PACS, etc.) Companies
• 3.11 Software (PACS and RIS)

4. Regulations and Standards

• 4.1 HIPAA
  • 4.1.1 Title I: Healthcare Access, Portability and Renewability
  • 4.1.2 Title II: Preventing Healthcare Fraud and Abuse, Administrative Simplification and Medical Liability Reform
  • 4.1.2.1 The Privacy Rule
  • 4.1.2.2 The Transactions and Code Sets Rule
  • 4.1.2.3 The Security Rule
  • 4.1.2.4 The Unique Identifiers Rule (National Provider Identifier)
  • 4.1.2.5 The Enforcement Rule
• 4.2 DICOM
  • 4.2.1 History
  • 4.2.2 DICOM Data Format
  • 4.2.3 DICOM Services
    • 4.2.3.1 Store
    • 4.2.3.2 Storage Commitment
    • 4.2.3.3 Query/Retrieve
    • 4.2.3.4 Modality Worklist
    • 4.2.3.5 Modality Performed Procedure Step
    • 4.2.3.6 Printing
    • 4.2.3.7 Off-line Media (DICOM Files)
  • 4.2.4 Application Areas
• 4.3 HL7
  • 4.3.1 What Does the Name HL7 Mean?
  • 4.3.2 Why HL7?
  • 4.3.3 How is HL7 Organized?
  • 4.3.4 New and Ongoing Initiatives
    • 4.3.4.1 HIPAA
    • 4.3.4.2 The Reference Information Model (RIM)
• 4.4 Clinical Data Interchange Standards Consortium
• 4.5 The IHE
• 4.6 Optimal Patient Care
• 4.7 The Four Steps of the Process
• 4.8 The Technical Framework-Business and Technology Together
• 4.9 Leading by Example
• 4.10 IHE and the EHR
• 4.11 Nuclear Medicine Special Issues
  • 4.11.1 SNM and the IHE
  • 4.11.2 Problems interfacing PACS and NM
  • 4.11.3 The IHE Nuclear Medicine Profile
  • 4.11.4 The Next Step
• 4.12 Government Healthcare Initiatives Creates Opportunities for PACS Vendors

5. Technology Trends

• 5.1 Content-based Image Retrieval (CBIR)
• 5.2 Digital Dashboard
• 5.3 Digital Dashboard Example: PACSPulse
• 5.4 Paperless Workflow in PACS
• 5.5 Process and Workflow Example for RIS PACS Integration
• 5.6 Process and Workflow Example for High Speed CT

6. Company Profiles

• 6.1 Agfa-Gevaert Corp.
• 6.2 Canon
• 6.3 Carestream Health, Inc. (Formerly Kodak Health Imaging Division)
• 6.4 Cerner Corporation
• 6.5 DR Systems
• 6.6 Dynamic Imaging
• 6.7 Emageon
• 6.8 FujiFilm Medical Systems USA
• 6.9 GE Healthcare (RIS/PACS)
• 6.10 Hitachi Medical Systems America
• 6.11 IBM (PACS)
• 6.12 IMCO Technologies
• 6.13 Intelerad Medical System
• 6.14 McKesson Corporation
• 6.15 Merge Healthcare (Acquired eMed Technologies)
• 6.16 Philips Medical Systems (PACS)
• 6.17 ScImage
• 6.18 Siemens Medical Solutions (RIS/PACS)
• 6.19 SmartPACS (Newly Renamed to Infinitt)
• 6.20 Thinking Systems Corporation

7. Manufacturers

INDEX OF FIGURES

• Figure 2.1: Total Spending on Healthcare in the U.S., 1960-2007
• Figure 2.2: International Per Capita Healthcare Spending by Country, 2006
• Figure 3.1: Representative PACS Architecture
• Figure 3.2: PACS Facilities Shown by Number of Exams/Procedures Performed Per Year
• Figure 3.3: Modalities Offered by PACS Facilities
• Figure 3.4: US Facilities with PACS
• Figure 3.5: PACS Installation Duration
• Figure 3.6: Number of Vendors Evaluated
• Figure 3.7 Ranking of PACS Evaluation Factors
• Figure 3.8 PACS Features Considered in Evaluating PACS
• Figure 3.9 PACS Vendor Aspects Considered in Evaluating PACS
• Figure 3.10: Number of Service Calls
• Figure 3.11: PACS Satisfaction
• Figure 3.12: Vendor' s US Market Share
• Figure 4.1: IHE Technical Framework
• Figure 4.2: IHE Framework Organization
• Figure 5.1: Digital Dashboard
• Figure 5.2: PACSPulse Architecture
• Figure 5.3: The Usage and Performance Dashboard
• Figure 5.4: Paper Versus Paperless PACS Workflow
• Figure 5.5: PACS Workflow Example for a CT System

INDEX OF TABLES

• Table 2.1: U.S. Medical Imaging Market Size, 2001-2010
• Table 2.2: Global Medical Imaging Market Size, 2001-2010
• Table 2.3: U.S. User Expenditures for Medical Imaging Equipment and Related Products, 2000-2007
• Table 2.4: Total Number of Americans Over 65 Years of Age, 2000-2050
• Table 2.5: Hospital Survey
• Table 2.6: Percent Change in Volume of Examinations Per Imaging Modality between 1993 and 2004
• Table 2.7: Worldwide Market Share Medical Imaging Companies
• Table 2.8: Worldwide Imaging Procedures, 2001-2010
• Table 2.9: Penetration Rates of PACS in U.S. Hospitals, 2006-2012
• Table 3.1: List of Vendors
• Table 3.2: U.S. Market for PACS, 2004-2012
• Table 3.3: Worldwide and Regional Markets for PACS, 2004-2012
• Table 3.4: European PACS Expenditures, 2004-2012
• Table 3.5: ECRI Criteria for PACS Evaluation
• Table 3.6: Healthcare Leadership Council
• Table 3.7: Healthcare Leadership Council Summary of HIT Benefits
• Table 3.8: PACS Placements by Facility Type
• Table 3.9: Vendor' s US Market Share
• Table 4.1: IHE Actors and Transactions
• Table 5.1: The Usage and Performance Dashboard

Positron Emission Tomography (PET) Markets

1. Overview

• 1.1 Statement of Report
• 1.2 Scope of this Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Overview of the Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiologic Services
  • 2.2.5 Medical Imaging Companies
  • 2.2.6 Medical Imaging Market Drivers
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for PET Imaging
  • 2.2.9 Key Players in the PET Imaging Segment
  • 2.2.10 Medical Imaging Sector Analysis
• 2.3 Structure and Use of PET Imaging
  • 2.3.1 Functional Imaging versus Anatomic Imaging
  • 2.3.2 Functional Imaging Using Single-Photon Imaging (SPECT)
  • 2.3.3 PET in Clinical Use
  • 2.3.4 PET Sensitivity
  • 2.3.5 Therapeutic Uses of PET
  • 2.3.6 PET/CT
  • 2.3.7 The Future of PET in Cancer Imaging
  • 2.3.8 PET Reimbursement
• 2.4 Radiopharmaceutical Imaging
  • 2.4.1 Cardinal Health Acquires PET Radiopharmaceutical Production Facilities
  • 2.4.2 GE Healthcare Launches New Platform for Automated Synthesis of PET Radiopharmaceuticals
  • 2.4.3 Siemens Medical PETNET Radiopharmacy
  • 2.4.4 Future Growth of PET Imaging Procedures
  • 2.4.5 Diagnostic Radiopharmaceuticals: Market Analysis and Future Prospects
  • 2.4.6 New Radiopharmaceutical Applications

3. PET Market

• 3.1 Market Size
• 3.2 Total PET and PET/CT Market Trends
  • 3.2.1 Market Segmentation and Definitions
  • 3.2.2 Overview
  • 3.2.3 Market Measurements
  • 3.2.4 Market Drivers
  • 3.2.5 Market Restraints
  • 3.2.6 Future Needs for Market Development
  • 3.2.7 Clinical Usages
• 3.3 Total PET and PET/CT Market Forecasts
  • 3.3.1 Revenue Forecasts
  • 3.3.2 Unit Shipment Forecasts
  • 3.3.3 Procedure Forecast
  • 3.3.4 Competitive Structure
  • 3.3.5 Market Share Analysis
  • 3.3.6 Future Directions for PET
  • 3.3.7 New PET Technology Platforms
• 3.4 SPECT Market Forecasts
• 3.5 Stand-Alone PET Market Forecasts
  • 3.5.1 Revenue Forecasts
  • 3.5.2 Unit Shipment Forecasts
  • 3.5.3 Market Share Analysis
• 3.6 PET/CT Market Forecasts
  • 3.6.1 PET/CT Revenue Forecasts
  • 3.6.2 PET/CT Unit Shipment Forecasts
  • 3.6.3 PET/CT Market Share Analysis
• 3.7 Products
  • 3.7.1 Gamma Medica
  • 3.7.2 Mallinckrodt
  • 3.7.3 Naviscan PET Systems
  • 3.7.4 Siemens Medical
  • 3.7.5 TeraRecon
  • 3.7.6 Toshiba America Medical Systems
  • 3.7.7 CTI Molecular Imaging Inc.
  • 3.7.8 GE Healthcare
  • 3.7.9 Philips Medical Systems
  • 3.7.10 MedImage Inc.

4. PET/CT

• 4.1 Strengths of CT and PET Scanning
• 4.2 Combining CT' s Strengths with PET Scanning
• 4.3 Nuclear Medicine Safety Protocols
• 4.4 PET Safety Protocols
  • 4.4.1 Radiation Safety
  • 4.4.2 Appropriate Shielding
  • 4.4.3 Radioactive Package Protocols
• 4.5 Regulatory Requirements
• 4.6 PET and SPECT Tracers
  • 4.6.1 FDG Centers
• 4.7 PET Imaging
• 4.8 PET and Cancer Staging
• 4.9 PET/CT Reimbursement

5. Hybrid Technology: PET/CT and SPECT/CT

• 5.1 PET/CT
• 5.2 SPECT/CT
  • 5.2.1 Blending of Technology Platforms
  • 5.2.2 SPECT vs. PET

6. SPECT and SPECT/CT

• 6.1 Single-Photon Emission Computed Tomography (SPECT)
  • 6.1.1 SPECT Imaging
  • 6.1.2 SPECT Instrumentation
  • 6.1.3 SPECT Market
• 6.2 SPECT/CT
  • 6.2.1 Differences between PET and SPECT
• 6.3 Potential Applications of SPECT/CT
  • 6.3.1 SPECT/CT in Cardiology
  • 6.3.2 Myocardial Perfusion Imaging
  • 6.3.3 Functional Brain Imaging
  • 6.3.4 SPECT/CT in General Nuclear Medicine
  • 6.3.5 SPECT/CT in Neurology
  • 6.3.6 Oncology Applications
• 6.4 New Technology Platforms: SPECT
  • 6.4.1 Future Growth

7. Clinical PET/CT for Oncology Applications

• 7.1 Pulmonary Nodules
• 7.2 Non-Small-Cell Lung Cancer
• 7.3 Melanoma
• 7.4 Lymphoma
• 7.5 Colorectal Cancer
• 7.6 Head and Neck Cancer
• 7.7 Esophageal Cancer
• 7.8 Breast Cancer
• 7.9 Brain Cancer
• 7.10 Prostate Cancer
• 7.11 Ovarian Cancer
• 7.12 Cervical Cancer
• 7.13 Testicular Cancer
• 7.14 Thyroid Cancer
• 7.15 Pancreatic Cancer
• 7.16 Trends in Clinical Use of PET/CT
• 7.17 Development of PET/MRI

8. Company Listings

Appendix 1. Radiopharmaceutical Diagnostic Imaging Agent Codes and PET Scan Services

LIST OF TABLES

• Table 2.1: U.S. Medical Imaging Market Size, 2001 to 2010
• Table 2.2: Global Medical Imaging Market Size, 2001 to 2010
• Table 2.3: U.S. Healthcare Expenditures, 1999 to 2010
• Table 2.4: U.S. Health Expenditures as a Percentage of GDP, 1999 to 2010
• Table 2.5: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 2.6: Millions of Americans Over 65 Years of Age, 2000 to 2050
• Table 2.7: Hospital Survey
• Table 2.8: U.S. Radiological Images Taken, 1999 to 2010
• Table 2.9: Worldwide Market Share Medical Imaging and Diagnostic Companies
• Table 2.10: U.S. Nuclear Medicine Procedures, 2002 to 2010
• Table 2.11: PET Radioisotopes
• Table 3.1: Type of Imaging Offered by Facility
• Table 3.2: PET Procedures by Type
• Table 3.3: PET Patient Studies Performed in U.S.
• Table 3.4: Worldwide Dollar Sales of PET Imaging Systems, 2004 to 2011
• Table 3.5: U.S. Dollar Sales of PET Imaging Systems, 2004 to 2011
• Table 3.6: Average Selling Price for PET, U.S. and Worldwide, 2004 to 2011
• Table 3.7: Unit Sales of PET Imaging Systems, U.S. and Worldwide, 2004 to 2011
• Table 3.8: Installed Base of PET Imaging Systems, U.S., 2004 to 2011
• Table 3.9: PET Procedure Volume, 2004 to 2011
• Table 3.10: FDG Sales, 2004 to 2011
• Table 3.11: SPECT Procedure Volume, 2004 to 2011
• Table 3.12: U.S. SPECT Scanner Market Size and Growth, 2002 to 2010
• Table 3.13: U.S. Stand-Alone PET Scanner Market Size and Growth, 2004 to 2011
• Table 3.14: U.S. PET/CT Scanner Market Size and Growth, 2002 to 2010
• Table 4.1: PET Applications Approved for Reimbursement by CMS
• Table 5.1: SPECT and PET Hybrid Sales Percentages

Ultrasound Markets

1. Overview

• 1.1 Statement of Report
• 1.2 Scope of the Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Overview of the Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Industry Profile
  • 2.2.1 Healthcare Delivery System Profile
  • 2.2.2 Radiologists
  • 2.2.3 Radiologic Services
  • 2.2.4 Medical-Image Market Drivers and Restraints
  • 2.2.5 Medical Imaging Market Segments
  • 2.2.6 Contrast Media
  • 2.2.7 Picture Archiving and Communication Systems
  • 2.2.8 Picture Archiving and Communication Systems and Radiology Information Systems
  • 2.2.9 Medical Imaging Companies
  • 2.2.10 Significant Ultrasound Companies
  • 2.2.11 Medical Imaging Industry Forecasts
• 2.3 Market Niches and Digitalization
• 2.4 Digital Imaging Techniques
  • 2.4.1 Clinical Uses
• 2.5 Current and New Digital Imaging Procedures
• 2.6 The Digital Impact on Clinical Imaging Markets
• 2.7 Trends in Digital Imaging
• 2.8 Enhancing Computed Radiography
• 2.9 Digital Radiography vs. Computed Radiography
• 2.10 DR Products
• 2.11 Vasodilator Perfusion Imaging

3. Ultrasound Market

• 3.1.1 Overview of Ultrasound Market Segments
• 3.1.2 Increase in Application Areas Stirs Demand
• 3.2 Ultrasound Market Trends
  • 3.2.1 Market Segmentation and Definitions
  • 3.2.2 Ultrasonography Is of Great Value in Other Obstetric Conditions such as:
  • 3.2.3 Overview
  • 3.2.4 Market Developments
  • 3.2.5 Market Drivers
  • 3.2.6 Market Restraints
• 3.3 Ultrasound Market Forecasts
  • 3.3.1 Unit Shipment Forecasts
  • 3.3.2 Installed-Base Forecast
  • 3.3.3 Competitive Structure
  • 3.3.4 Market Analysis
• 3.4 Cardiology Ultrasound Segment Forecasts
  • 3.4.1 Unit Shipment Forecasts
  • 3.4.2 Market Share Analysis
• 3.5 OB/GYN Ultrasound Segment Forecasts
• 3.6 Radiology Ultrasound Segment Forecasts
• 3.7 Hand-Carried Ultrasound Segment Forecasts
  • 3.7.1 Market Share Analysis
  • 3.7.2 Portable Ultrasound Equipment Displays Rapid Growth
• 3.8 Contrast Media
  • 3.8.1 Market Share Analysis
  • 3.8.2 Contrast-Enhanced Ultrasound (CEUS) and Microbubbles
  • 3.8.3 Targeting Microbubbles
  • 3.8.4 How Contrast-Enhanced Ultrasound (CEUS) Works
  • 3.8.5 Applications of Contrast-Enhanced Ultrasound
• 3.9 Products
  • 3.9.1 The Acquisition Decision
  • 3.9.2 Ardent Sound
  • 3.9.3 ALOKA, Ltd.
  • 3.9.4 B-K Medical
  • 3.9.5 CIVCO Medical Solutions
  • 3.9.6 Esaote Group Company
  • 3.9.7 Fischer Medical Technologies
  • 3.9.8 GE Healthcare
  • 3.9.9 Hitachi Medical Systems America
  • 3.9.10 Medison Co., Ltd.
  • 3.9.11 MEDRAD
  • 3.9.12 Mindray Co., Ltd.
  • 3.9.13 Philips Medical
  • 3.9.14 Sea Ridge Software
  • 3.9.15 Siemens Medical
  • 3.9.16 SonoSite
  • 3.9.17 Sony Medical Products
  • 3.9.18 TeraRecon
  • 3.9.19 Toshiba America Medical Systems
  • 3.9.20 U-Systems
  • 3.9.21 Zonare Medical Systems
• 3.10 Manufacturers
• 3.11 New Transducer Technology
• 3.12 Ultrasound Product Introductions to the Market

4. Three- and Four-Dimensional Ultrasonography Markets

• 4.1 Total 3D Imaging Market Trends
  • 4.1.1 Overview
  • 4.1.2 Market Drivers
  • 4.1.3 Market Restraints
• 4.2 Total 3D Imaging Market Forecasts
• 4.3 Three-Dimensional Ultrasound Imaging Market Forecasts
• 4.4 Three-Dimensional Imaging Markets
  • 4.5.1 Echocardiography: The Largest Growth Area
  • 4.5.2 Real-Time Color Doppler System
• 4.6 Manufacturers

5. Business Trends in the Industry

• 5.1 Sector Consolidation
• 5.2 Medical Imaging Growth Trends
• 5.3 Acquisition, License Agreements, Internal Development and Partnerships
• 5.4 Mergers and Acquisitions
  • 5.4.1 Center for Diagnostic Imaging Signs With Medicalis
  • 5.4.2 HealthSouth Sells Diagnostic Division to The Gores Group
  • 5.4.3 AMICAS Acquires Technology Partners' Practice-Management Software
  • 5.4.4 MDS Nordion and Avid Radiopharmaceuticals Enter Collaboration
  • 5.4.5 NightHawk Radiology Holdings Acquired Teleradiology Diagnostic Service
  • 5.4.6 Onex Acquires Kodak' s Health Group
  • 5.4.7 Successor to Kodak' s Health Group To Be Called "Carestream Health"
  • 5.4.8 Siemens Acquires German HIS Company
  • 5.4.9 Siemens Medical Finalizes Acquisition of Bayer' s Diagnostics Division
• 5.5 Product Testing Depth in Medical-Imaging Testing
• 5.6 Government Regulation
  • 5.6.1 U.S. Regulation
  • 5.6.2 U.K. Regulation
  • 5.6.3 E.U. Regulation
  • 5.6.4 Japanese Regulation
• 5.7 Increased Market Penetration
• 5.8 Partnerships

6. Company Profiles

• 6.1 Agfa-Gevaert Corp. Heartlab
• 6.3 Analogic Corp.
• 6.4 Biosound Esaote
• 6.5 Boston Scientific
• 6.6 B-K Medical
• 6.7 GE Healthcare
• 6.8 Hitachi Medical Systems America, Inc.
• 6.9 Hologic, Inc.
• 6.10 Medison Co., Ltd.
• 6.11 MEDRAD, Inc. (U.S.)
• 6.12 Philips Medical Systems
• 6.13 Siemens Medical Solutions
• 6.14 SonoSite, Inc. (U.S.)
• 6.15 Toshiba America Medical Systems
• 6.16 Varian Medical Systems, Inc.

INDEX OF FIGURES

• Figure 2.1: U.S. Annual Percent Increase in Imaging Market Size, 2003 to 2012
• Figure 2.2: Worldwide Annual Percent Increase in Imaging Market Size, 2002 to 2011
• Figure 2.3: Global Market Share of Contrast Media Markets
• Figure 2.4: Global Market Share of Medical Imaging and Diagnostic Companies
• Figure 3.1: Annual Increase in Worldwide Sales of Ultrasound Equipment, 2001 to 2010
• Figure 3.2: Annual Increase U.S. Sales of Ultrasound Equipment, 2001 to 2010
• Figure 3.3: Annual Increase in Worldwide Sales of Cardiology Ultrasound Equipment, 2001 to 2010
• Figure 3.4: U.S. Annual Increase in Worldwide Sales of Cardiology Ultrasound Equipment, 2001 to 2010
• Figure 3.5: Annual Increase in U.S. Sales of Handheld Ultrasound Equipment, 2001 to 2010
• Figure 3.6: Annual Increase in Worldwide Sales of Ultrasound Contrast Agents, 2000 to 2010

LIST OF TABLES

• Table 2.1: U.S. Medical Imaging Market Size, 2001 to 2012
• Table 2.2: Global Medical Imaging Market Size, 2001 to 2012
• Table 2.3: U.S. Healthcare Expenditures
• Table 2.4: U.S. Health Expenditures as a Percentage of GDP, 1998 to 2010
• Table 2.5: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 2.6: Comparison of Spending on Health by Country
• Table 2.7: Spending on Health by Country
• Table 2.8: Millions of Americans Over 65 Years of Age, 2000 to 2050
• Table 2.9: Percent Change in Volume of Examinations per Imaging Modality: 1996 to 2006
• Table 2.10: Market Share of Contrast Media Markets
• Table 2.11: Worldwide Market Share of Medical Imaging and Diagnostic Companies
• Table 2.12: Worldwide Imaging Procedures, 2001 to 2012
• Table 3.1: Ultrasonography Comparison: U.S. vs. Europe
• Table 3.2: Worldwide Ultrasound Procedures, 2000 to 2010
• Table 3.3: Worldwide Sales of Ultrasound Equipment, 2000 to 2010
• Table 3.4: U.S. Sales of Ultrasound Equipment, 2000 to 2010
• Table 3.5: Worldwide Cardiology Ultrasound Procedures
• Table 3.6: Worldwide Sales of Cardiology Ultrasound Equipment, 2000 to 2010
• Table 3.7: U.S. Sales of Cardiology Ultrasound Equipment, 2000 to 2010
• Table 3.8: Worldwide Sales of Handheld Ultrasound Equipment, 2000 to 2012
• Table 3.9: U.S. Sales of Handheld Ultrasound Equipment, 2000 to 2012
• Table 3.10: Worldwide Sales of Ultrasound Contrast Agents, 1999 to 2010